Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Psychosomatics. 2006 Jan-Feb;47(1):62-7.

Responsiveness of the PHQ-9 to Psychopharmacological Depression Treatment.

Author information

  • 1Dept. of General Internal and Psychosomatic Medicine, Heidelberg Univ. Medical Center, Germany. bernd.loewe@med.uni-heidelberg.de

Abstract

This is the first study that investigates the responsiveness of the Patient Health Questionnaire-9 (PHQ-9), a standard 9-item self-report depression scale, to antidepressant medication. Authors analyzed data from 1,788 depressed outpatients (66.8% women; mean age, 50.3 years), participating in a prospective, open-label, non-interventional, observational study of sertraline. On the 0-27-point PHQ-9 scale, the total sample gained 10.3 points at 12 weeks, corresponding to a standardized effect size of -1.85. With reference to two independent criterion standards, the PHQ-9 change scores were considerably greater in therapy responders than in nonresponders. The PHQ-9 was equally responsive in men and women. Therefore, the PHQ-9 qualifies as a practical tool for gauging response to pharmacological treatment in depressed patients.

PMID:
16384809
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk